Targeting Transcriptional AddiCTion In Cancer

Disrupting cancer’s transcriptional dependencies.
TACTIC unites leading labs across Germany to unlock therapies targeting the ‘undruggable’ — from RNA splicing kinases to chromatin remodelers and protein-interaction domains.

We build new modalities, share cutting-edge tools, and empower translational discovery across academia and industry.